Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Cisplatin × Clear all

Phase

Phase 1 6 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 199 Squamous Cell Carcinoma of Head and Neck 111 Head and Neck Neoplasms 103 Lung Neoplasms 98 Esophageal Neoplasms 76 Stomach Neoplasms 72 Urinary Bladder Neoplasms 51 Esophageal Squamous Cell Carcinoma 51 Uterine Cervical Neoplasms 49 Breast Neoplasms 47 Nasopharyngeal Carcinoma 44 Carcinoma, Squamous Cell 38 Small Cell Lung Carcinoma 35 Pancreatic Neoplasms 32 Neoplasms 32 Neoplasm Metastasis 29 Cholangiocarcinoma 28 Biliary Tract Neoplasms 27 Ovarian Neoplasms 26 Oropharyngeal Neoplasms 26 Mesothelioma, Malignant 25 Adenocarcinoma Of Esophagus 25 Adenocarcinoma of Lung 23 Lymphoma 21 Carcinoma, Ovarian Epithelial 19 Lymphoma, Large B-Cell, Diffuse 18 Carcinoma 18 Recurrence 16 Laryngeal Neoplasms 16 Nasopharyngeal Neoplasms 15

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1 dalpiciclib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05898451 2023-06-12

R-2

Refnot-Pharm Ltd

Phase 2 Completed

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡